Impact of S100A8/A9 expression on prostate cancer progression in vitro and in vivo

Journal of Cellular Physiology

Volumn 229, Issue 5, 2014, Pages 661-671

  Grebhardt, Sina ^a   Müller Decker, Karin ^b   Bestvater, Felix ^b   Hershfinkel, Michal ^c   Mayer, Doris ^a  

^a GERMAN CANCER RESEARCH CENTER   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN A; CALGRANULIN B; DOXYCYCLINE; MESSENGER RNA; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CELL INFILTRATION; CELL MIGRATION ASSAY; CELL PROLIFERATION ASSAY; CELL VIABILITY ASSAY; COLONY FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; LYMPH NODE; MALE; MICROMETASTASIS; MUSCLE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; TUMOR INVASION; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES; CALGRANULIN A; CALGRANULIN B; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; MALE; MICE; NEOPLASMS, EXPERIMENTAL; PROSTATIC NEOPLASMS;

EID: 84892636453     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24489     Document Type: Article

References (49)

1. Austyn JM, Gordon S. 1981. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 11:805-815.
2. Baron U, Freundlieb S, Gossen M, Bujard H. 1995. Co-regulation of two gene activities by tetracycline via a bidirectional promoter. Nucleic Acids Res 23:3605-3606.
3. Berens C, Hillen W. 2003. Gene regulation by tetracyclines. Constraints of resistance regulation in bacteria shape TetR for application in eukaryotes. Eur J Biochem 270:3109-3121.
4. Chandran UR, Ma C, Dhir R, Bisceglia M, Lyons-Weiler M, Liang W, Michalopoulos G, Becich M, Monzon FA. 2007. Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC Cancer 7:64-85.
5. Cheng P, Corzo CA, Luetteke N, Yu B, Nagaraj S, Bui MM, Ortiz M, Nacken W, Sorg C, Vogl T, Roth J, Gabrilovich DI. 2008. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J Exp Med 205:2235-2249.
6. Daley JM, Thomay AA, Connolly MD, Reichner JS, Albina J. 2008. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol 83:64-70.
7. Donato R. 2001. S100: A multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33:637-668.
8. Donato R, Cannon BR, Sorci G, Riuzzi F, Hsu K, Weber DJ, Geczy CL. 2013. Functions of S100 proteins. Curr Mol Med 13:24-57.
9. Ehrchen JM, Sunderkotter C, Foell D, Vogl T, Roth J. 2009. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol 86:557-566.
10. Fleming TJ, Fleming ML, Malek TR. 1993. Selective expression of Ly-6C on myeloid lineage cells in mouse bone marrow. J Immunol 151:2399-2408.
11. Foell D, Wittkowski H, Vogl T, Roth J. 2007. S100 proteins expressed in phagocytes: A novel group of damage-associated molecular pattern molecules. J Leukoc Biol 81:28-37.
12. Gebhardt C, Németh J, Angel P, Hess J. 2006. S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol 72:1622-1631.
13. Ghavami S, Kerkhoff C, Chazin WJ, Kadkhoda K, Xiao W, Zuse A, Hashemi M, Eshraghi M, Schulze-Osthoff K, Klonisch T, Los M. 2008a. S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2. Biochim Biophys Acta 1783:297-311.
14. Ghavami S, Rashedi I, Dattilo BM, Eshraghi M, Chazin WJ, Hashemi M, Wesselborg S, Kerkhoff C, Los M. 2008b S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J Leukoc Biol 83:1484-1492.
15. Ghavami S, Chitayat S, Hashemi M, Eshraghi M, Chazin WJ, Halayko AJ, Kerkhoff C. 2009. S100A8/A9: A Janus-faced molecule in cancer therapy and tumorgenesis. Eur J Pharmacol 625:73-83.
16. Grebhardt S, Veltkamp C, Ströbel P, Mayer D. 2012. Hypoxia and HIF-1 increase S100A8 and S100A9 expression in prostate cancer. Int J Cancer 131:2785-2794.
17. Hermani A, Hess J, De Servi B, Medunjanin S, Grobholz R, Trojan L, Angel P, Mayer D. 2005. Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer. Clin Cancer Res 11:5146-5152.
18. Hermani A, De Servi B, Medunjanin S, Tessier PA, Mayer D. 2006. S100A8 and S100A9 activate MAP kinase and NF-κB signalling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp Cell Res 312:184-197.
19. Hermiston ML, Xu Z, Weiss A. 2003. CD45: A critical regulator of signaling thresholds in immune cells. Annu Rev Immunol 21:107-137.
20. Hessian PA, Edgeworth J, Hogg N. 1993. MRP-8 and MRP-14, two abundant Ca(2+)-binding proteins of neutrophils and monocytes. J Leukoc Biol 53:197-204.
21. Hiratsuka S, Watanabe A, Aburatani H, Maru Y. 2006. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 8:1369-1375.
22. Hiratsuka S, Watanabe A, Sakurai Y, Akashi-Takamura S, Ishibashi S, Miyake K, Shibuya M, Akira S, Aburatani H, Maru Y. 2008. The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat Cell Biol 10:1349-1355.
23. Holness CL, Simmons DL. 1993. Molecular cloning of CD68, a human macrophage marker telated to lysosomal glycoproteins. Blood 81:1607-1613.
24. Ichikawa M, Williams R, Eang L. 2011. S100A8/A9 activate key genes and pathways in colon tumor progression. Mol Cancer Res 9:133-148.
25. Kälberg E, Vogl T, Liberg D, Olsson A, Björk P, Wikström P, Bergh A, Roth J, Ivars F, Leanderson T. 2012. S100A9 interaction with TLR4 promotes tumor growth. PLoS ONE 7:e34207.
26. Kerkhoff C, Voss A, Scholzen TE, Averill MM, Zänker KS, Bornfeldt KE. 2012. Novel insights into the role of S100A8/A9 in skin biology. Exp Dermatol 21:822-826.
27. Klebanoff SJ. 2005. Myeloperoxidase: Friend and foe. J Leukoc Biol 77:598-625.
28. Liu Y, Kosaka A, Ikeura M, Kohanbash G, Fellows-Mayle W, Snyder LA, Okada H. 2013. Premetastatic soil and prevention of breast cancer brain metastasis. Neuro Oncol 15:891-903.
29. Marenholz I, Heizmann CW, Fritz G. 2004. S100 proteins in mouse and man: From evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun 322:1111-1122.
30. Miao L, Grebhardt S, Shi J, Peipe I, Zhang J, Mayer D. 2012. Prostaglandin E2 stimulates S100A8 expression by activating protein kinase A and CCAAT/enhancer-binding-protein-beta in prostate cancer cells. Int J Biochem Cell Biol 44:1919-1928.
31. Moon A, Yong HY, Song JI, Cukovic D, Salagrama S, Kaplan D, Putt D, Kim H, Dombkowski A, Kim HR. 2008. Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion. Mol Cancer Res 6:1544-1553.
32. Nacken W, Sorg C, Kerkhoff C. 2004. The myeloid expressed EF-hand proteins display a diverse pattern of lipid raft association. FEBS Lett 572:289-293.
33. Németh J, Stein I, Haag D, Riehl A, Longerich T, Horwitz E, Breuhahn K, Gebhardt C, Schirmacher P, Hahn M, Ben-Neriah Y, Pikarsky E, Angel P, Hess J. 2009. S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis. Hepatology 50:1251-1262.
34. Pulford KAF, Sipos A, Cordell JL, Stross WP, Mason DY. 1990. Distribution of the CD68 macrophage/myeloid associated antigen. Int Immunol 2:973-980.
35. Rammes A, Roth J, Goebeler M, Klempt M, Hartmann M, Sorg C. 1997. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem 272:9496-9502.
36. Ryckman C, McColl SR, Vandal K, de Medicis R, Lussier A, Poubelle PE, Tessier PA. 2003a. Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis. Arthritis Rheum 48:2310-2320.
37. Ryckman C, Vandal K, Rouleau P, Talbot M, Tessier PA. 2003b. Proinflammatory activities of S100: Proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol 170:3233-3242.
38. Sade-Feldman M, Kanterman J, Ish-Shalom E, Elnekave M, Horwith E, Baniyash M. 2013. Tumor necrosis factor-α blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation. Immunity 38:541-554.
39. Saha A, Lee YC, Zhang Z, Chandra G, Su SB, Mukherjee AB. 2010. Lack of an endogenous anti-inflammatory protein in mice enhances colonization of B16F10 melanoma cells in the lungs. J Biol Chem 285:10822-10831.
40. Santamaria-Kisiel L, Rintala-Dempsey AC, Shaw GS. 2006. Calcium-dependent and -independent interactions of the S100 protein family. Biochem J 396:201-214.
41. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A. 2012. Fiji: An open-source platform for biological-image analysis. Nat Methods 9:676-682.
42. Schmitt M, Pawlita M. 2009. High-throughput detection and multiplex identification of cell contaminations. Nucleic Acids Res 37:e119.
43. Sunahori K, Yamamura M, Yamana J, Takasugi K, Kawashima M, Yamamoto H, Chazin WJ, Nakatani Y, Yui S, Makino H. 2006. The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis. Arthritis Res Ther 8:R69.
44. Turovskaya O, Foell D, Sinha P, Vogl T, Newlin R, Nayak J, Nguyen M, Olsson A, Nawroth PP, Bierhaus A, Varki N, Kronenberg M, Freeze HH, Srikrishna G. 2008. RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis 29:2035-2043.
45. Viemann D, Strey A, Janning A, Jurk K, Klimmek K, Vogl T, Hirono K, Ichida F, Foell D, Kehrel B, Gerke V, Sorg C, Roth, J. 2005. Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. Blood 105:2955-2962.
46. Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MA, Nacken W, Foell D, van der Poll T, Sorg C, Roth J. 2007. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 13:1042-1049.
47. Voss A, Bode G, Sopalla C, Benedyk M, Varga G, Bohm M, Nacken W, Kerkhoff C. 2010. Expression of S100A8/A9 in HaCaT keratinocytes alters the rate of cell proliferation and differentiation. FEBS Lett 585:440-446.
48. Wiechert L, Németh J, Pusterla T, Bauer C, De Ponti A, Manthey S, Marhenke S, Vogel A, Klingmüller U, Hess J, Angel P. 2012. Hepatocyte-specific S100a8 and S100a9 transgene expression in mice causes Cxcl1 induction and systemic neutrophil enrichment. Cell Commun Signal 10:40.
49. Yui S, Nakatani Y, Mikami M. 2003. Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol Pharm Bull 26:753-760.